Calliditas Therapeutics Stock Price on December 31, 2022
| CALT Stock | USD 37.95 15.53 69.27% |
If you're considering investing in Calliditas Stock, it is important to understand the factors that can impact its price. As of today, the current price of Calliditas Therapeutics stands at 37.95, as last reported on the 30th of May, with the highest price reaching 38.32 and the lowest price hitting 35.89 during the day. Calliditas Therapeutics is not too volatile given 3 months investment horizon. Calliditas Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We were able to break down and interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 1.25% are justified by taking the suggested risk. Use Calliditas Therapeutics Downside Deviation of 3.24, mean deviation of 4.01, and Risk Adjusted Performance of 0.0911 to evaluate company specific risk that cannot be diversified away.
At this time, Calliditas Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Sale Purchase Of Stock is likely to gain to 0.00 in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 1 B in 2024. . At this time, Calliditas Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 43.63 in 2024, whereas Price Earnings To Growth Ratio is likely to drop (2.68) in 2024. Calliditas Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Calliditas |
Sharpe Ratio = 0.1322
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CALT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.45 actual daily | 83 83% of assets are less volatile |
Expected Return
| 1.25 actual daily | 24 76% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Calliditas Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Calliditas Therapeutics by adding it to a well-diversified portfolio.
Price Book 16.341 | Enterprise Value Ebitda (1.38) | Price Sales 0.4522 | Shares Float 37.5 M | Wall Street Target Price 41.5 |
Calliditas Therapeutics Valuation on December 31, 2022
It is possible to determine the worth of Calliditas Therapeutics on a given historical date. On December 31, 2022 Calliditas was worth 17.93 at the beginning of the trading date compared to the closed value of 17.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Calliditas Therapeutics stock. Still, in general, we apply an absolute valuation method to find Calliditas Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Calliditas Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Calliditas Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 17.48 | 18.31 | 16.65 | 18.31 | 10,165 | |
12/30/2022 | 17.93 | 17.99 | 16.50 | 17.00 | 9,790 |
| 18.36 | 18.81 | 17.63 | 18.11 | 8,200 |
| Backtest Calliditas Therapeutics | | | Calliditas Therapeutics History | | | Calliditas Therapeutics Valuation | Previous | Next |
Calliditas Therapeutics Trading Date Momentum on December 31, 2022
| On January 03 2023 Calliditas Therapeutics was traded for 18.11 at the closing time. The top price for the day was 18.81 and the lowest listed price was 17.63 . The trading volume for the day was 8.2 K. The trading history from January 3, 2023 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 6.53% . The overall trading delta against the current closing price is 9.00% . |
Calliditas Therapeutics Fundamentals Correlations and Trends
By evaluating Calliditas Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Calliditas Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Calliditas financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Calliditas Therapeutics Stock history
Calliditas Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Calliditas is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Calliditas Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Calliditas Therapeutics stock prices may prove useful in developing a viable investing in Calliditas Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 53.7 M | 42.4 M | |
| Net Loss | -371 M | -352.5 M |
Calliditas Therapeutics Quarterly Net Working Capital |
|
Calliditas Therapeutics Stock Technical Analysis
Calliditas Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Calliditas Therapeutics Period Price Range
Low | December 30, 2022
| High |
17.93 | 17.00 |
Calliditas Therapeutics May 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Calliditas Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Calliditas Therapeutics shares will generate the highest return on investment. By undertsting and applying Calliditas Therapeutics stock market strength indicators, traders can identify Calliditas Therapeutics entry and exit signals to maximize returns
Calliditas Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Calliditas Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Calliditas Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Calliditas to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0911 | |||
| Jensen Alpha | 1.3 | |||
| Total Risk Alpha | 0.8792 | |||
| Sortino Ratio | 0.3848 | |||
| Treynor Ratio | (0.96) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Calliditas Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Calliditas Stock please use our How to Invest in Calliditas Therapeutics guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Calliditas Stock analysis
When running Calliditas Therapeutics' price analysis, check to measure Calliditas Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calliditas Therapeutics is operating at the current time. Most of Calliditas Therapeutics' value examination focuses on studying past and present price action to predict the probability of Calliditas Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calliditas Therapeutics' price. Additionally, you may evaluate how the addition of Calliditas Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Calliditas Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Calliditas Therapeutics. If investors know Calliditas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Calliditas Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 44.972 | Quarterly Revenue Growth 0.052 | Return On Assets (0.13) | Return On Equity (0.85) |
The market value of Calliditas Therapeutics is measured differently than its book value, which is the value of Calliditas that is recorded on the company's balance sheet. Investors also form their own opinion of Calliditas Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Calliditas Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Calliditas Therapeutics' market value can be influenced by many factors that don't directly affect Calliditas Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Calliditas Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Calliditas Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Calliditas Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.